Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients
Abraham et al.
Blood Advances
July 2019
Authors and Affiliates
Allistair A. Abraham,1,* Tami D. John,2,3,* Michael D. Keller,1 C. Russell N. Cruz,1 Baheyeldin Salem,1 Lauren Roesch,1 Hao Liu,4 Fahmida Hoq,1 Bambi J. Grilley,2,3 Adrian P. Gee,2,3 Hema Dave,1 David A. Jacobsohn,1 Robert A. Krance,2,3 Elizabeth. J. Shpall,2,3 Caridad A. Martinez,2,3 Patrick J. Hanley,1,† and Catherine M. Bollard1,†
1Center for Cancer and Immunology Research, Children’s National Health System and Department of Pediatrics, The George Washington University, Washington, DC; 2Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX; 3Texas Children’s Hospital, Houston, TX; and 4Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN